Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

19.93

-0.14 (-0.70%)

At close: Aug 13, 2026, 4:00 PM EDT

19.99

+0.06 (0.30%)

Pre-market: Aug 14, 2026, 6:01 AM EDT

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	121.19	84.02	124.29	143.74	151.79	280.12
Short-Term Investments	789.75	470.5	657.04	606.35	847.12	677.95
Cash & Short-Term Investments	910.93	554.52	781.32	750.09	998.92	958.07
Cash Growth	38.70%	-29.03%	4.16%	-24.91%	4.26%	41.30%
Accounts Receivable	-	-	-	-	0.31	0.4
Other Current Assets	17.15	23.76	27.88	20.02	20.28	17.77
Total Current Assets	928.08	578.28	809.2	770.1	1,020	976.24
Net Property, Plant & Equipment	38.04	41.72	57.67	68.87	75.39	27.32
Other Intangible Assets	-	-	2.3	2.3	2.3	2.3
Other Long-Term Assets	1.34	1.34	2.12	2.71	2.58	2.58
Total Assets	967.46	621.33	871.3	843.98	1,100	1,008
Accounts Payable	11.46	7.71	14.1	9.21	10.58	8.28
Accrued Expenses	34.08	13.65	21.24	14.89	22.7	13.56
Current Portion of Leases	4.01	3.77	5.73	4.96	4.28	1.84
Unearned Revenue	-	-	7.68	-	-	0.25
Other Current Liabilities	1.25	0.46	1.99	1.2	26.15	0.4
Total Current Liabilities	50.8	25.58	50.73	30.27	63.71	24.32
Long-Term Leases	26.64	28.69	42.78	48.5	53.47	21.06
Other Long-Term Liabilities	-	-	-	13.21	32.38	65.26
Total Long-Term Liabilities	26.64	28.69	42.78	61.71	85.84	86.31
Total Liabilities	77.45	54.27	93.5	91.98	149.55	110.64
Common Stock	0.21	0.17	0.17	0.13	0	0.11
Additional Paid-in Capital	3,063	2,581	2,517	2,153	2,019	1,667
Accumulated Other Comprehensive Income	-1.55	0.73	-0.99	-0.2	-10.42	-1.09
Retained Earnings	-2,172	-2,015	-1,738	-1,401	-1,059	-768.1
Shareholders' Equity	890.01	567.06	777.79	752	950.22	897.81
Total Liabilities & Equity	967.46	621.33	871.3	843.98	1,100	1,008
Total Debt	30.66	32.46	48.5	53.47	57.74	22.9
Net Cash (Debt)	880.28	522.06	732.82	696.62	941.18	935.17
Net Cash Growth	41.39%	-28.76%	5.20%	-25.98%	0.64%	43.07%
Net Cash Per Share	4.83	3.04	5.13	5.68	8.39	9.83
Book Value	890.01	567.06	777.79	752	950.22	897.81
Book Value Per Share	4.89	3.30	5.44	6.13	8.47	9.44
Tangible Book Value	890.01	567.06	775.49	749.7	947.92	895.51
Tangible Book Value Per Share	4.89	3.30	5.43	6.12	8.45	9.41

SEC Filings: 10-K · 10-Q